The Next Comment Deadlines Need Specific, Testable Requests
The seven days ending September 27 added a busy group of analyses, but the practical lesson is consistent: the most useful comments identify the evidence an agency used, the people or organizations affected, and the safeguard or alternative that would make the decision more reliable.
What Changed This Week
The repository added 14 summary files during the week. They cover financial-crime controls, Privacy Act exemptions, shareholder-proposal and proxy-solicitation rules, contractor-employee appeals, federal personnel systems, medical-device and nonclinical-testing policy, air-quality plans, small-business eligibility, and Medicare pharmacy contracting. Two of the most time-sensitive records close almost immediately: the EPA's Puerto Rico proposal on September 28, followed by the CFTC and FinCEN records on October 1.
The new reviews also make a useful distinction between a proposal's policy goal and the record needed to implement it. Several agencies describe a plausible objective, while leaving the public to ask for a facility inventory, a reproducible calculation, a narrower alternative, or a correction process.
Dockets Worth Attention Now
1) EPA-R02-OAR-2026-2741 — Puerto Rico oil-and-gas negative declaration
Why it matters: EPA is considering approval of Puerto Rico's negative declaration for the oil-and-gas industry under the federal air-pollution framework. If the finding is correct, the state does not need to submit a plan for facilities that are not present. If a qualifying facility was missed or later appears, the response path matters.
What stands out in the visible record: The notice and supporting material describe an inventory review and a certification that no qualifying facilities were identified, but the supplied record does not show the inventory universe, search date, screening criteria, or facility-level exclusions. The analysis describes the legal pathway as coherent while treating the underlying screening record as the central uncertainty. Comments are due September 28.
High-value comment angle: Ask EPA and Puerto Rico's environmental agency to publish the inventory scope, search method, screening results, and definition-by-definition treatment of borderline facilities. Also ask for the temporal, geographic, and source-category limits of the approval and the process for revisiting it if conditions change.
2) CFTC-2026-0893 — Privacy Act regulations and reopened comments
Why it matters: The proposal would create or maintain broad Privacy Act exemptions for certain investigative records. Confidentiality can protect sources and active investigations, but categorical exemptions can also affect whether people learn what records exist or can correct inaccurate information.
What stands out in the visible record: The local analyses cover both the substantive NPRM and the notice reopening its comment period. They find a plausible investigative rationale but insufficiently defined boundaries for the covered records, closed cases, retention review, and later accuracy checks. The current export lists October 1 as the local-time deadline.
High-value comment angle: Support protection for active investigations and confidential sources, then ask CFTC to distinguish those records from routine or closed-case material. Request record-level inclusion criteria, a protected correction or audit path, retention review, and a comparison of redaction, delayed access, segregation, and post-investigation review.
3) FINCEN-2026-0232 — Special measure concerning Banque Misr UAE
Why it matters: FinCEN proposes a full correspondent-access prohibition and related controls based on a finding about Iranian illicit finance. A measure of this kind can affect financial institutions' screening, account relationships, and handling of indirect transactions, so the scope and error-correction mechanics matter alongside the national-security rationale.
What stands out in the visible record: FinCEN describes 103 potential Iranian shadow-banking front companies and approximately $1.8 billion in transactions, but the underlying analysis is partly non-public and the export does not show a public methodology, uncertainty range, or complete covered-entity crosswalk. The local record lists October 1 as the comment deadline.
High-value comment angle: Ask FinCEN to explain how the 103-company and transaction estimates were identified, de-duplicated, validated, and tested for uncertainty. Request a comparison of full prohibition with targeted, conditional, phased, or reviewable controls, plus matching examples, false-positive handling, good-faith expectations, escalation, and correction before termination where feasible.
4) SBA-2026-0199 — Small Business Size Standards
Why it matters: Size standards help determine which firms qualify for federal small-business programs, contracts, loans, and other assistance. A threshold change can expand eligibility overall while producing concentrated effects within particular industries or changing access to set-asides.
What stands out in the visible record: SBA proposes 338 updated standards and a policy of not reducing any industry standard, while the analysis says the underlying Revised Methodology and calculation files are not separately available in the supplied export. The proposal also describes a net 1.8% increase in eligible firms, a figure that can conceal different effects by industry and program. The current export lists November 20 as the local-time deadline and estimates 2,518 public comments.
High-value comment angle: Ask SBA to publish the Revised Methodology and calculation files, identify the industries where the no-reduction policy changes the result, and provide current-versus-proposed firm counts by NAICS group and threshold type. Request program-by-program effects, including who gains or loses access to set-asides, loans, funding, or regulatory flexibility.
5) FDA-2025-N-6224 — Class I medical-device accessories
Why it matters: FDA proposes a list of accessories that could be treated as Class I devices distinct from their parent devices. That could reduce premarket requirements for some products, making the boundary between general controls and device-specific risks especially important.
What stands out in the visible record: The proposal has a clear statutory and administrative structure, but the available record does not show the item-specific risk, compatibility, and alternative-analysis basis for all seven proposed categories. The analysis identifies October 16 as the local-time comment deadline.
High-value comment angle: Ask FDA for an item-by-item table connecting each category and product code to intended use, principal risks, applicable controls, residual uncertainty, and the reason design controls are unnecessary. Request operational examples for generic, hybrid, and parent-device-specific accessories, along with postmarket monitoring and reassessment triggers.
Comment Activity To Watch
The current local export shows activity concentrated in the SBA record rather than a broad trend across the week's newly analyzed dockets. It estimates 2,518 public comments there, with 344 captured public records, 372 records in the representative analysis sample, and 255 unique clusters. Its sampled net sentiment signal is -0.32. Those figures are useful for triage, not a poll: the repository's counts and sentiment values are based on captured and sampled records, and a small or empty sample does not show that a docket lacks public importance.
For the other featured records, the current snapshot contains zero captured public comments for CFTC and EPA-R02, one for FinCEN, and two for the FDA accessories docket. That is a reason to read the notice and add specific evidence, not a reason to assume the issue is settled.
Newly Published Analysis
This week's analyses add several concrete starting points for commenters: an auditable facility-screening record for Puerto Rico; accuracy and delayed-review safeguards for CFTC investigative records; a public methodology and proportionality comparison for FinCEN; reproducible calculations and distributional effects for SBA; and category-specific risk crosswalks for FDA.
The other new reviews extend the same pattern. The SEC shareholder-proposal analysis asks commenters to compare full rescission with narrower access-preserving alternatives. The DOE contractor-protection analysis focuses on evidence for new deadlines and safeguards against broad extension discretion. The OPM excepted-service review asks for transition, publication, and cross-agency audit controls. A CMS item is substantively a request for information even though its metadata labels it a proposed rule; it should be read as an invitation to supply implementation facts, not as a final proposal of contracting standards.
Method Note
The local docket export was generated September 28, after this reporting window, and is marked degraded because the live open-docket query was incomplete and a prior open snapshot was merged. It contains 73 records. Treat rankings, deadlines, comment estimates, and sampled sentiment as practical signals from the available local snapshot—not as a complete list, a validated measure of public opinion, or a legal conclusion. Always check the docket's current notice before submitting a comment.
If You Do One Thing This Week
If you can act before September 28, read EPA-R02-OAR-2026-2741 and ask for the inventory and screening record behind the negative declaration. Otherwise, choose one of the October 1 records and make one focused request: identify the evidence, explain the real-world effect, and name the safeguard or narrower alternative you want the agency to consider.